Dept. of Internal Medicine, American Univ. of Beirut, P.O. Box, Lebanon.
Am J Physiol Renal Physiol. 2013 Sep 1;305(5):F613-7. doi: 10.1152/ajprenal.00173.2013. Epub 2013 Jul 3.
Increasing evidence nowadays is showing that obesity by itself, independent of other comorbidities like diabetes and hypertension, is associated with renal functional changes and structural damage. Intentional weight loss demonstrates beneficial reduction in proteinuria and albuminuria in patients with mild to moderate chronic kidney disease, particularly those whose renal damage is likely induced by obesity. The safety of some weight loss interventions, particularly the use of high-protein diets and/or medications, is questionable in this population due to the lack of well-designed randomized controlled studies reporting on their efficacy or harm. Bariatric surgery showed the most promising results with regards to ameliorating glomerular hyperfiltration and albuminuria albeit with a modest risk of increased perioperative complications with advanced stages of chronic kidney disease (CKD).
如今越来越多的证据表明,肥胖本身,与糖尿病和高血压等其他合并症无关,与肾功能变化和结构损伤有关。在轻度至中度慢性肾病患者中,特别是那些肾脏损伤可能由肥胖引起的患者中,有目的的体重减轻可减少蛋白尿和白蛋白尿。由于缺乏设计良好的随机对照研究报告其疗效或危害,某些减肥干预措施的安全性(特别是高蛋白饮食和/或药物的使用)在该人群中值得怀疑。尽管在慢性肾脏病(CKD)的晚期,手术风险略有增加,但减重手术在改善肾小球高滤过和白蛋白尿方面显示出最有希望的结果。